Oxidized low-density lipoprotein and adiponectin levels in pregnancy

References

• Diagnosis and classification of diabetes mellitus. Diabetes Care 2006;29(Suppl 1):S43–S48.
   PubMed Web of Science ®Google Scholar
• Gestational Diabetes Mellitus. American Diabetes Association. Diabetes Care 2003;(Suppl 1):S103–S105.
   Google Scholar
• Hadden DR. Geographic, ethnic, and racial variations in the incidence of gestational diabetes mellitus. Diabetes 1985;34 (Suppl 2):8–12.
   PubMedGoogle Scholar
• Abrams B, Parker J. Overweight and pregnancy complications. Int J Obes 1988;12(4):293–303.
   PubMed Web of Science ®Google Scholar
• Jarvie E, Hauguel-de-Mouzon S, Nelson SM, Sattar N, Catalano PM, Freeman DJ. Lipotoxicity in pregnant women and its potential role in adverse pregnancy outcome and obesity in the offspring. Clin Sci 2010;119:123–129.
   PubMed Web of Science ®Google Scholar
• Pou KM, Massaro JM, Hoffmann U, Vasan RS, Maurovich-Horvat P, Larson MG, Keaney Jr JF, Meigs JB, Lipinska I, Kathiresan S, Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation 2007;116:1234–1241.
   PubMed Web of Science ®Google Scholar
• Catalano PM, Huston L, Amini SB, Kalhan SC. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 1999;180:903–916.
   PubMed Web of Science ®Google Scholar
• Chen X, Scholl TO. Oxidative stress: changes in pregnancy and with gestational diabetes mellitus. Curr Diab Rep 2005;5: 282–288.
   PubMedGoogle Scholar
• Paradisi G, Biaggi A, Ferrazzani S, De Carolis S, Caruso A. Abnormal carbohydrate metabolism during pregnancy: association with endothelial dysfunction. Diabetes Care 2002;25: 560–564.
   PubMed Web of Science ®Google Scholar
• Catalano PM, Ehrenberg HM. The short and long-term implications of maternal obesity on the mother and her offspring. Br J Obstet Gynaecol 2006;113:1126–1133.
   Google Scholar
• Sanchez-Vera I, Bonet B, Viana M, Quintanar A, Martin MD, Blanco P, Donnay S, Albi M. Changes in plasma lipids and increased low-density lipoprotein susceptibility to oxidation in pregnancies complicated by gestational diabetes: consequences of obesity. Metab Clin Exp 2007;56:1527–1533.
   PubMed Web of Science ®Google Scholar
• Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114:1752–1761.
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N. The fat-derived hormone adiponectin reverses insulin-resistance associated with both lipoatrophy and obesity. Nat Med 2001;7(8):941–946.
   PubMed Web of Science ®Google Scholar
• Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 2002;8:1211–1217.
   PubMed Web of Science ®Google Scholar
• Fraley AE, Tsimikas S. Clinical applications of circulating oxidized low-density lipoprotein biomarkers in cardiovascular disease. Curr Opin Lipidol 2006;17:502–509.
   PubMed Web of Science ®Google Scholar
• Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006;440:944–948.
   PubMed Web of Science ®Google Scholar
• Evans JL, Maddux BA, Goldfine ID. The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal 2005;7:1040–1052.
   PubMed Web of Science ®Google Scholar
• Ishigaki Y, Oka Y, Katagiri H. Circulating oxidized LDL: a biomarker and pathogenic factor. Curr Opin Lipidol 2009;20: 363–369.
   PubMed Web of Science ®Google Scholar
• Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004;24:29–33.
   PubMed Web of Science ®Google Scholar
• Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Hiraoka H, Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003; 23:85–89.
   PubMed Web of Science ®Google Scholar
• Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000;20:1595–1599.
   PubMed Web of Science ®Google Scholar
• Li R, Wang WQ, Zhang H, Yang X, Fan Q, Christopher TA, Lopez BL, Tao L, Goldstein BJ, Gao F, Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activity. Am J Physiol Endocrinol Metab 2007;293:E1703–E1708.
   PubMed Web of Science ®Google Scholar
• Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79–83.
   PubMed Web of Science ®Google Scholar
• Prior SL, Gable DR, Cooper JA, Bain SC, Hurel SJ, Humphries SE, Stevens JW. Association between the adiponectin promoter rs266729 gene variant and oxidative stress in patients with diabetes mellitus. Eur Heart J 2009;30:1263–1269.
   PubMed Web of Science ®Google Scholar
• Hattori S, Hattori Y, Kasai K. Hypoadiponectinemia is caused by chronic blockade of nitric oxide synthesis in rats. Metabolism 2005;54:482–487.
   PubMed Web of Science ®Google Scholar
• Panidis D, Farmakiotis D, Rousso D, Koliakos G, Kaltsas Th, Krassas G. Decrease in adiponectin levels in women with polycystic ovary syndrome after an oral glucose tolerance test. Fertil Steril 2005;83:232–234.
   PubMed Web of Science ®Google Scholar
• English PJ, Coughlin SR, Hayden K, Malik IA, Wilding JP. Plasma adiponectin increases postprandially in obese but not in lean subjects. Obes Res 2003;11:839–844.
   PubMedGoogle Scholar
• Van Linthout S, Foryst-Ludwig A, Spillmann F, Peng J, Feng Y, Meloni M, Van Craeyveld E, Kintscher U, Schultheiss H-P, De Geest B, Impact of HDL on adipose tissue metabolism and adiponectin expression. Atherosclerosis 2010;210:438–444.
   PubMed Web of Science ®Google Scholar
• Nakanishi S, Yamane K, Kamei N, Nojima H, Okubo M, Kohno N. A protective effect of adiponectin against oxidative stress in Japanese Americans: the association between adiponectin or leptin and urinary isoprostane. Metabolism 2005;54:194–199.
   PubMed Web of Science ®Google Scholar